Patents by Inventor Raphael Barkan

Raphael Barkan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8673979
    Abstract: S-alkylsiothiouronium derivatives such as S-ethylisothiouronium diethylphosphate are used for the treatment of headaches, in particular, migraines, as well as for the prevention or treatment of nausea and vomiting. The compositions of the invention are also effective in preventing or alleviating emesis associated with migraines or other medical conditions such as chemotherapy or radiotherapy, as well as other symptoms of migraines including phonophobia and photophobia.
    Type: Grant
    Filed: October 18, 2006
    Date of Patent: March 18, 2014
    Assignee: Meditor Pharmaceuticals Ltd.
    Inventors: Raphael Barkan, Alexander Mirimsky
  • Publication number: 20070088005
    Abstract: S-alkylsiothiouronium derivatives such as S-ethylisothiouronium diethylphosphate are used for the treatment of headaches, in particular, migraines, as well as for the prevention or treatment of nausea and vomiting. The compositions of the invention are also effective in preventing or alleviating emesis associated with migraines or other medical conditions such as chemotherapy or radiotherapy, as well as other symptoms of migraines including phonophobia and photophobia.
    Type: Application
    Filed: October 18, 2006
    Publication date: April 19, 2007
    Applicant: Meditor Pharmaceuticals Ltd.
    Inventors: Raphael Barkan, Alexander Mirimsky
  • Patent number: 7148208
    Abstract: S-alkylsiothiouronium derivatives such as S-ethylisothiouronium diethylphosphate are used for the treatment of headaches, in particular, migraines, as well as for the prevention or treatment of nausea and vomiting. The compositions of the invention are also effective in preventing or alleviating emesis associated with migraines or other medical conditions such as chemotherapy or radiotherapy, as well as other symptoms of migraines including phonophobia and photophobia.
    Type: Grant
    Filed: March 5, 2003
    Date of Patent: December 12, 2006
    Assignee: Meditor Pharmaceuticals Ltd.
    Inventors: Raphael Barkan, Alexander Mirimsky
  • Publication number: 20040006044
    Abstract: S-alkylsiothiouronium derivatives such as S-ethylisothiouronium diethylphosphate are used for the treatment of headaches, in particular, migraines, as well as for the prevention or treatment of nausea and vomiting. The compositions of the invention are also effective in preventing or alleviating emesis associated with migraines or other medical conditions such as chemotherapy or radiotherapy, as well as other symptoms of migraines including phonophobia and photophobia.
    Type: Application
    Filed: March 5, 2003
    Publication date: January 8, 2004
    Applicant: MEDITOR PHARMACEUTICALS LTD.
    Inventors: Raphael Barkan, Alexander Mirimsky